FIGS (NYSE:FIGS) CEO Sells $565,972.92 in Stock

FIGS, Inc. (NYSE:FIGS) CEO Catherine Eva Spear sold 49,734 shares of the firm’s stock in a transaction on Tuesday, January 6th. The stock was sold at an average price of $11.38, for a total value of $565,972.92. Following the transaction, the chief executive officer directly owned 1,857,299 shares of the company’s stock, valued at $21,136,062.62. The trade was a 2.61% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

FIGS Trading Down 1.8%

Shares of NYSE:FIGS traded down $0.21 on Thursday, hitting $11.77. The company had a trading volume of 2,350,768 shares, compared to its average volume of 1,947,864. The company has a market cap of $1.94 billion, a PE ratio of 117.70 and a beta of 1.30. FIGS, Inc. has a 52-week low of $3.57 and a 52-week high of $12.35. The business has a 50 day moving average of $10.48 and a 200 day moving average of $8.05.

FIGS (NYSE:FIGS) last announced its earnings results on Thursday, November 6th. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.02 by $0.03. FIGS had a net margin of 3.03% and a return on equity of 4.50%. The firm had revenue of $151.66 million during the quarter, compared to the consensus estimate of $142.39 million. During the same quarter in the previous year, the company posted ($0.01) EPS. The firm’s revenue for the quarter was up 8.2% on a year-over-year basis. As a group, equities analysts predict that FIGS, Inc. will post 0.01 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on FIGS. Barclays increased their price target on FIGS from $9.00 to $11.00 and gave the stock an “equal weight” rating in a research note on Tuesday. Telsey Advisory Group reissued a “market perform” rating and issued a $9.00 price target (up from $7.00) on shares of FIGS in a research note on Monday, November 3rd. The Goldman Sachs Group upped their price objective on shares of FIGS from $5.00 to $5.50 and gave the company a “sell” rating in a research note on Friday, November 7th. Morgan Stanley raised their target price on shares of FIGS from $5.25 to $7.50 and gave the stock an “equal weight” rating in a research report on Wednesday, November 19th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of FIGS in a research report on Monday, December 29th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, FIGS currently has a consensus rating of “Hold” and a consensus target price of $9.60.

Institutional Investors Weigh In On FIGS

Several institutional investors and hedge funds have recently bought and sold shares of FIGS. Jacobs Levy Equity Management Inc. grew its holdings in shares of FIGS by 27.2% during the third quarter. Jacobs Levy Equity Management Inc. now owns 1,976,705 shares of the company’s stock worth $13,224,000 after purchasing an additional 422,277 shares during the last quarter. PharVision Advisers LLC acquired a new stake in FIGS in the 3rd quarter valued at about $328,000. Polymer Capital Management US LLC bought a new stake in shares of FIGS during the third quarter valued at approximately $891,000. Quarry LP raised its position in FIGS by 1,876.3% in the 3rd quarter. Quarry LP now owns 7,846 shares of the company’s stock worth $52,000 after purchasing an additional 7,449 shares during the last quarter. Finally, Prelude Capital Management LLC bought a new position in FIGS in the third quarter valued at approximately $92,000. Institutional investors own 92.21% of the company’s stock.

FIGS Company Profile

FIGS, Inc operates as a direct-to-consumer designer and retailer of medical apparel and accessories. The company offers a range of products tailored to the needs of healthcare professionals, including scrub sets, lab coats, tops, bottoms, outerwear, footwear, and performance fabrics designed for comfort, durability, and antimicrobial protection. Through its e-commerce platform and a growing network of retail stores, FIGS provides customizable uniforms and accessories with a focus on innovative materials and functional design features such as four-way stretch fabrics, moisture-wicking technology, and multiple secure pockets.

Founded in 2013 by Heather Hasson and Trina Spear, FIGS set out to disrupt the traditional medical uniform market by emphasizing both form and function.